A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

BACKGROUND: Almost one-third of patients with major depressive disorder (MDD) do not respond to conventional antidepressants, and new treatments for MDD are urgently needed. OBJECTIVES: This phase IIb clinical trial was designed to evaluate the efficacy and safety of Anyu Peibo capsules in the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shen, Yu, Yimin, Huang, Jingjing, Yin, Jiahui, Niu, Yajuan, Lu, Yazhou, Wu, Bin, Fang, Maosheng, Wang, Xue, Tao, Zhiping, Li, Lehua, Li, Kan, Li, Yan, Ding, Xiujuan, Shen, Yifeng, Li, Huafang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666694/
https://www.ncbi.nlm.nih.gov/pubmed/38022835
http://dx.doi.org/10.1177/20451253231212342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666694/
https://www.ncbi.nlm.nih.gov/pubmed/38022835
http://dx.doi.org/10.1177/20451253231212342

Ejemplares similares